Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
64.50    -0.30 (-0.46%)
Bid:
64.50
Ask:
65.00
Spread: 0.50 (0.775%)
Market Cap: £100.40m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

Trading Update

28 Nov 2024 07:00

RNS Number : 9131N
Macfarlane Group PLC
28 November 2024
 

28 November 2024

MACFARLANE GROUP PLC

("MACFARLANE GROUP", "THE GROUP")

Trading Update

Effective response to market headwinds

Macfarlane Group PLC, the protective packaging specialist, today provides an update on trading for the period 1 January to 31 October 2024.

· The Board anticipates the Group's performance for 2024 will be broadly in line with its full year expectations.

· Revenue year to date is 4% below the same period last year, with continued challenging market conditions resulting in weaker volumes and lower pricing impacting most sectors.

· These impacts are being offset by improved new business performance, effective management of pricing and costs and the completion of two acquisitions during the period, both of which are performing well.

· The Group continues to progress its strong acquisitions pipeline.

· A strong balance sheet and cash generation, supported by a £35m bank facility, underpin the Group's strategy; net bank debt at 31 October 2024 was £4.7m (30 June 2024: Net bank funds of £0.8m), after £11.3m of investment in acquisitions and payment of dividends of £5.8m.

· The increase in employers' national insurance rates and National Minimum Wage announced in the UK Government Budget on 30 October 2024 will increase the Group's costs by c£1.5m annually from April 2025. Mitigation actions are currently being reviewed to minimise the impact.

Aleen Gulvanessian, Chair of Macfarlane Group, said:

"As outlined in our Interim Results, the management team is responding effectively to the market headwinds. Our strong balance sheet gives us confidence we can continue to execute accretive acquisitions. There is good new business momentum as customers increasingly recognise the added value we can offer both on an environmental and cost savings basis. The Group remains well-positioned to benefit when the macro-economic outlook improves."

 

Further enquiries:

Macfarlane Group

Tel: 0141 333 9666

Aleen Gulvanessian Chair

Peter Atkinson Chief Executive

Ivor Gray Finance Director

Spreng Thomson

Callum Spreng

Mob: 07803 970103

 

Legal Entity Identifier (LEI): 213800LVRYDERSJAAZ73

Notes to Editors:

· Macfarlane Group PLC has been listed on the Main Market of the London Stock Exchange plc (LSE: MACF) since 1973 with over 70 years' experience in the UK packaging industry.

· Through its two divisions, Macfarlane Group services a broad range of business customers, supplying them with high quality protective packaging products which help customers reduce supply chain costs, improve operational efficiencies and sustainability and enhance their brand presentation. The divisions are:

o Packaging Distribution - Macfarlane Packaging Distribution is the leading UK distributor of a comprehensive range of protective packaging products; and

o Manufacturing Operations - Macfarlane Design and Manufacture is a UK market leader in the design and production of protective packaging for high value and fragile products.

· Headquartered in Glasgow, Scotland, Macfarlane Group employs over 1,000 people at 40 sites, principally in the UK, as well as in Ireland, Germany and the Netherlands.

· Macfarlane Group supplies more than 20,000 customers, principally in the UK and Europe.

· In partnership with 1,700 suppliers, Macfarlane Group distributes and manufactures 600,000+ lines supplying to a wide range of sectors, including: retail e-commerce; consumer goods; food; logistics; mail order; electronics; defence; medical; automotive; and aerospace.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSRLSLDFIS
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
12th May 20263:30 pmRNSExtension of Share Buyback Programme
12th May 20263:28 pmRNSResult of AGM
12th May 20267:00 amRNSAGM Trading Update
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
6th May 20262:26 pmRNSHolding(s) in Company
5th May 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSNotice of AGM
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:40 amRNSDirector/PDMR Shareholdings
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 202612:12 pmRNSDirector/PDMR Shareholdings
2nd Mar 20268:26 amRNSHolding(s) in Company
2nd Mar 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSAnnual Results 2025
23rd Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202611:02 amRNSHolding(s) in Company
16th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:01 amRNSNotice of Results & Investor Presentation
9th Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
22nd Dec 20258:12 amRNSTransaction in Own Shares
22nd Dec 20258:12 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTrading Update
17th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20258:27 amRNSHolding(s) in Company
10th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 202511:57 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.